Are you Looking to Buy Corlanor (Ivabradine) from PrescriptionPoint.

Corlanor Information

Corlanor (Ivabradine) is a first-ever HCN Channel Blocker which helps with the symptoms of chronic cardiac pain and heart failure. It is prescribed in conjunction with other medications, like beta-blockers, and lifestyle changes to create a treatment plan for the patients showing prolonged symptoms of heart failure. It reduces the risk of hospitalization and surgery.

A prescription must be provided for Corlanor as with all prescription medicine here at Prescription Point. You must fax a copy of your prescription. Following that, you must mail the actual original prescription to Prescription Point. No exceptions.

In the US, customers can order Corlanor or it’s generic equivalent (Ivabradine) online from Prescription Point. Our Canadian online pharmacy allows you to purchase medication 24 hours a day and 7 days a week.

Prescription Point guarantees the best price for Corlanor and will beat any price found on a CIPA certified website for the same drug by 5 dollars.

Prescription Point proudly displays its CIPA (Canadian International Pharmacy Association) seal. This seal signals that we conform to nothing but the highest standards for quality. Our CIPA affiliate pharmacy is recognized globally as the first choice in prescription and non-prescription medicine.

If you have any questions regarding medication or basic inquiries about Prescription Point you can contact us by mail, phone or internet. If you wish to speak to a representative be sure to call our toll free number 1-877-244-0431 from Monday to Friday from 6am to 6pm and Saturdays from 7am to 4pm.

Prescription Point boasts a strong record of satisfied customers, as demonstrated by numerous positive reviews and testimonials.

It takes approximately 2 to 4 weeks from the day you order it to arrive at your house.

FAQ’s

How much does Corlanor cost?

The price of 56 Corlanor 5mg tablets is $155 plus a flat $9.95 shipping fee.

How should I take Corlanor?

• Take Corlanor exactly as prescribed by your healthcare provider.
• Take this medicine at the same time each day, with or without food.
• Take Corlanor regularly to get the most benefit from it.
• Do not crush, chew, or break the tablets before swallowing.
• Do not double the dose to catch up.
• Do not stop taking Corlanor suddenly without consulting your doctor, as it may worsen your condition.
• Avoid alcohol while taking Corlanor, as it may increase the risk of side effects such as dizziness or fainting.
• Avoid driving or operating heavy machinery until you know how Corlanor affects you as it might cause dizziness.

When should Corlanor not be taken?

Corlanor should not be used if you have:

• Acute decompensated heart failure
• Clinically significant hypotension
• Sick sinus syndrome, sinoatrial block, or third-degree AV block, unless a functioning demand pacemaker is present
• Clinically significant bradycardia
• Severe hepatic impairment
• Heart rate maintained exclusively by the pacemaker
• In combination with strong cytochrome CYP3A4 inhibitors

What are the side effects?

Common Side Effects

• Bradycardia (slow heart rate)
• High blood pressure
• Dizziness
• Headache
• Temporary visual brightness or light disturbances

Serious Side Effects

• Atrial fibrillation
• Heart rhythm problems
• Fainting or feeling faint
• Shortness of breath or difficulty breathing

What precaution should I follow?

• Fetal Toxicity: If you are a woman of childbearing age, you should use effective contraception while taking Corlanor.
• Atrial Fibrillation Monitoring: Regularly monitor patients for signs of atrial fibrillation.
• Heart Rate Monitoring: Monitor for decreases in heart rate and symptoms of bradycardia during treatment.
• Second-Degree AV Block: Corlanor is not recommended if you have a second-degree AV block.

How should Corlanor be stored?

• Store Corlanor tablets at room temperature, around 25°C (77°F).
• Keep Corlanor in its original packaging to protect it from light and moisture.
• Keep out of reach of children and pets.

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209964lbl.pdf